Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
Status
Conditions
Treatments
Details and patient eligibility
About
The goal of this clinical trial is to study the value and feasibility of magnetic resonance imaging in detection of bone marrow metastases
Full description
The patient was diagnosed as bone metastasis by pathology. CT showed no bone marrow biopsy site metastasis (anterior iliac spine or posterior iliac spine). After functional magnetic resonance examination, bone marrow biopsy was performed. Functional magnetic resonance imaging includes conventional SE sequence, T2W SPAIR, e-THRIVE,DWI,IVIM. With bone marrow biopsy as the gold standard, the sensitivity, specificity and coincidence rate of functional MRI in the diagnosis of bone marrow metastasis were evaluated.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients with malignant tumors (solid tumors or hematological malignancies) were definitely diagnosed by pathology or cytology.
- patients with bone metastases confirmed by more than two imaging examinations.
- Age 18-75.
- ECOG score: 0-2.
- The expected survival time is more than 3 months.
- Sign the informed consent.
Exclusion criteria
- Imaging findings suggest that bone metastases are present at the bone marrow puncture site.
- The patient refused bone marrow puncture.
- Puncture site with infection.
- Severe coagulation dysfunction.
- There are implanted instruments in the body, so magnetic resonance imaging can not be performed.
Trial design
Primary purpose
Allocation
Interventional model
Masking
50 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal